review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1399-5618.2005.00197.X |
P698 | PubMed publication ID | 15898959 |
P2093 | author name string | Peter Bräunig | |
L Trevor Young | |||
Stephanie Krüger | |||
P2860 | cites work | A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. | Q30884720 |
Lamotrigine in the treatment of bipolar depression | Q33753309 | ||
Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 | ||
Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 | ||
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder | Q35985601 | ||
Benzodiazepines and catatonia: an overview | Q38367760 | ||
A pilot study of loading versus titration of valproate in the treatment of acute mania | Q40615953 | ||
Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology | Q41707553 | ||
Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects | Q41917893 | ||
Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 | ||
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
Extending indications for long-term pharmacotherapy: opportunities and challenges | Q43843034 | ||
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 | ||
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers | Q43931805 | ||
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
Use of topiramate in treatment-resistant bipolar spectrum disorders. | Q44097703 | ||
Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain | Q44120358 | ||
A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
Quetiapine in the treatment of rapid cycling bipolar disorder. | Q44247110 | ||
Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 | ||
Acute dysphoric mania: treatment response to olanzapine versus placebo | Q44364152 | ||
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting | Q44408619 | ||
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
Antidepressant treatment in bipolar versus unipolar depression | Q44710957 | ||
Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 | ||
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy | Q44794381 | ||
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode | Q44801076 | ||
A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 | ||
New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine | Q47883104 | ||
Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. | Q50951201 | ||
Correlates of suicidal ideation in dysphoric mania. | Q51083618 | ||
Dysphoric mania. Clinical and biological correlates. | Q51178585 | ||
Relevance of the catatonic syndrome to the mixed manic episode | Q51948867 | ||
Does the manic/mixed episode distinction in bipolar disorder patients run true over time? | Q51964779 | ||
Treatment of mixed mania. | Q52069887 | ||
Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. | Q52078644 | ||
The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance | Q52112284 | ||
Clinical studies on the use of lamotrigine in bipolar disorder. | Q53944372 | ||
Diagnosis and treatment of mixed mania. | Q54413597 | ||
P433 | issue | 3 | |
P921 | main subject | pharmacotherapy | Q701216 |
P304 | page(s) | 205-215 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Bipolar Disorders | Q15716681 |
P1476 | title | Pharmacotherapy of bipolar mixed states | |
P478 | volume | 7 |
Q36836746 | Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran |
Q35073872 | Antimanic treatments in bipolar mixed states |
Q48886105 | Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients |
Q51910730 | Calming the bipolar storm: treating acute mania and mixed episodes in patients with bipolar disorder. |
Q58040107 | Clinical Features and Subtypes of Bipolar Disorder |
Q38097098 | Clinical assessment and crisis intervention for the suicidal bipolar disorder patient |
Q37219749 | Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder |
Q36881398 | Epidemiology, diagnosis and management of mixed mania |
Q37423318 | Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder |
Q30319923 | Mixed affective disorders |
Q34610837 | Oxcarbazepine in bipolar disorder: a critical review of the literature |
Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
Q37910665 | Sleep deprivation in mood disorders |
Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
Q41638870 | The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features |
Q40128111 | The prevalence of mixed episodes during the course of illness in bipolar disorder |
Q57730484 | Treatment of bipolar depression |
Q37280843 | Treatment of bipolar disorder: new perspectives |
Q37973144 | Treatment of mixed bipolar states |
Search more.